Outlooks

Bruxelles Woluwe

The PK world is currently evolving from a descriptive explanatory tool towads a predictive modelling patient-centered method that allows proactive anticipations and individualized treatments through the identification of biomarkers. However, even if data are generated everyday, there is a lack of exhaustive unification of information. Our ambition is now to explore a more exhaustive and innovative track in pharmacotherapy that is the creation of a multi-omics integrative network for predicting drug PK (figure 7).